Research programme: ciclosporin A analogues - Enanta

Drug Profile

Research programme: ciclosporin A analogues - Enanta

Alternative Names: Ciclosporin A analogues research programme - Enanta; Cyclosporin A analogues research programme - Enanta; EP 012637; EP 314; Research programme: cyclosporin A analogues - Enanta

Latest Information Update: 04 Feb 2011

Price : $50

At a glance

  • Originator Enanta Pharmaceuticals
  • Class Cyclic peptides
  • Mechanism of Action T cell activation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma

Most Recent Events

  • 19 May 2003 This programme is still in active development
  • 10 Jul 2002 Preclinical trials in Asthma in USA (Inhalation)
  • 10 Jul 2002 Enanta's cyclosporin A analogues are available for licensing in the USA (
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top